Expression of VIM in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

VIM is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2597.44

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

3393.6

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	9307.9
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	8422.3
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	7966.4
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	7111.1
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	6314.6
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	6274.6
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	6264.6
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	5995.5
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	5844.0
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	5782.9
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	5621.5
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	5614.0
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	5479.8
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	5471.6
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	5468.1
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	5379.4
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	5221.1
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	5189.2
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	5108.3
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	5081.6
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	5011.3
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	4952.3
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	4917.1
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	4907.1
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	4874.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	4786.4
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	4769.0
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	4640.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	4610.8
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	4562.0
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	4551.0
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	4462.5
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	4433.6
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	4330.3
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	4256.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	4248.5
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	4229.5
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	4211.6
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	4148.7
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4145.3
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	4142.8
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	4055.9
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	4020.6
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	3964.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	3930.5
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	3925.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	3888.6
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	3834.0
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	3817.7
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	3773.6
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	3761.3
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	3738.9
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	3736.3
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3721.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	3690.2
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	3661.9
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	3655.9
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	3631.9
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	3534.9
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	3532.8
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	3450.5
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3438.9
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	3424.6
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3423.1
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	3418.9
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	3403.7
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	3396.5
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	3390.9
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3389.5
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	3387.1
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	3377.8
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	3341.8
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3312.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	3311.3
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	3252.7
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3210.0
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	3165.3
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	3145.8
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3085.6
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	3062.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	3032.8
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	3026.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	3016.9
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	2861.1
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	2784.4
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2767.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2766.7
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2707.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2640.4
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2618.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2601.6
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2593.3
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2592.6
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2579.9
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2567.4
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2489.1
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2438.1
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2427.8
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	2419.0
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2414.2
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2392.7
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	2305.6
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	2272.7
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2271.2
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	2186.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2107.4
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2084.0
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2061.1
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2053.0
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1994.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1964.4
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	1961.2
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1927.0
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1922.2
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1880.6
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1853.2
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1817.5
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1762.3
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	1748.4
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1728.6
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1694.2
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	1675.8
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	1652.9
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1597.6
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1596.0
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1582.3
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1577.7
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1521.4
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1518.9
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1505.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1500.2
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	1499.9
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	1399.9
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1394.4
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1261.8
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1169.1
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1076.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	977.7
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	890.8
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	703.6
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	692.7
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

VIM is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2002.41

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2144.0

Number of samples

Samples

Sample	Description	pTPM
AK205	N, NA, stage:NA, dead, 120 days	5004.2
AK068	N, NA, stage:NA, alive, 360 days	4260.4
AK195	N, NA, stage:NA, dead, 390 days	3980.0
AK227	N, NA, stage:NA, alive, 300 days	3911.1
AK072	N, NA, stage:NA, dead, 150 days	3853.0
AK076	N, NA, stage:NA, alive, 660 days	3439.7
AK236	N, NA, stage:NA, dead, 360 days	3374.9
AK123	N, NA, stage:NA, dead, 180 days	3160.3
AK178	N, NA, stage:NA, dead, 240 days	3117.6
AK133	N, NA, stage:NA, dead, 360 days	3084.1
AK153	N, NA, stage:NA, dead, 240 days	2949.9
AK117	N, NA, stage:NA, dead, 210 days	2896.8
AK055	N, NA, stage:NA, dead, 240 days	2794.9
AK085	N, NA, stage:NA, alive, 660 days	2785.9
AK091	N, NA, stage:NA, dead, 210 days	2699.4
AK183	N, NA, stage:NA, alive, 360 days	2578.5
AK005	N, NA, stage:NA, dead, 240 days	2527.6
AK231	N, NA, stage:NA, dead, 240 days	2484.5
AK089	N, NA, stage:NA, dead, 330 days	2476.4
AK226	N, NA, stage:NA, dead, 360 days	2415.2
AK098	N, NA, stage:NA, dead, 660 days	2247.1
AK149	N, NA, stage:NA, dead, 420 days	2198.4
AK053	N, NA, stage:NA, dead, 300 days	2196.7
AK218	N, NA, stage:NA, dead, 180 days	2185.2
AK088	N, NA, stage:NA, dead, 360 days	2170.3
AK185	N, NA, stage:NA, alive, 330 days	2160.8
AK156	N, NA, stage:NA, dead, 330 days	2122.4
AK099	N, NA, stage:NA, dead, 420 days	2104.6
AK216	N, NA, stage:NA, dead, 360 days	2064.5
AK030	N, NA, stage:NA, dead, 120 days	2003.7
AK199	N, NA, stage:NA, alive, 1860 days	2001.2
AK103	N, NA, stage:NA, alive, 1320 days	1916.6
AK142	N, NA, stage:NA, alive, 90 days	1915.2
AK051	N, NA, stage:NA, dead, 360 days	1891.8
AK188	N, NA, stage:NA, alive, 420 days	1891.6
AK041	N, NA, stage:NA, alive, 810 days	1796.2
AK035	N, NA, stage:NA, dead, 210 days	1745.1
AK071	N, NA, stage:NA, dead, 540 days	1738.6
AK081	N, NA, stage:NA, dead, 180 days	1631.4
AK213	N, NA, stage:NA, alive, 2010 days	1623.9
AK049	N, NA, stage:NA, dead, 180 days	1616.2
AK139	N, NA, stage:NA, dead, 270 days	1577.0
AK100	N, NA, stage:NA, alive, 960 days	1566.2
AK074	N, NA, stage:NA, alive, 300 days	1485.3
AK003	N, NA, stage:NA, dead, 600 days	1440.4
AK006	N, NA, stage:NA, dead, 360 days	1377.2
AK043	N, NA, stage:NA, alive, 660 days	1366.5
AK079	N, NA, stage:NA, dead, 210 days	1231.2
AK158	N, NA, stage:NA, dead, 360 days	1218.5
AK002	N, NA, stage:NA, dead, 570 days	1141.2
AK015	N, NA, stage:NA, alive, 720 days	1042.6
AK167	N, NA, stage:NA, dead, 180 days	1042.1
AK134	N, NA, stage:NA, dead, 360 days	1004.0
AK173	N, NA, stage:NA, dead, 180 days	893.2
AK124	N, NA, stage:NA, alive, 1920 days	837.9
AK066	N, NA, stage:NA, alive, 960 days	797.5
AK102	N, NA, stage:NA, alive, 1740 days	667.4
AK165	N, NA, stage:NA, alive, 360 days	650.6
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0186100003	Tumor	1.4
CPT0125510003	Tumor	1.3
CPT0206000004	Tumor	1.0
CPT0218670003	Tumor	1.0
CPT0189570004	Tumor	0.9
CPT0093510003	Tumor	0.8
CPT0087730003	Tumor	0.7
CPT0205890003	Tumor	0.6
CPT0225730003	Tumor	0.6
CPT0127480003	Tumor	0.5
CPT0125570003	Tumor	0.5
CPT0225760003	Tumor	0.5
CPT0125220003	Tumor	0.5
CPT0182500003	Tumor	0.5
CPT0002410011	Tumor	0.4
CPT0217060003	Tumor	0.4
CPT0205780003	Tumor	0.4
CPT0206230003	Tumor	0.4
CPT0209440003	Tumor	0.4
CPT0093450003	Tumor	0.4
CPT0189750004	Tumor	0.4
CPT0190360004	Tumor	0.4
CPT0218330004	Tumor	0.4
CPT0217430008	Tumor	0.4
CPT0224540004	Tumor	0.4
CPT0093550003	Tumor	0.4
CPT0168480003	Tumor	0.4
CPT0079790003	Tumor	0.4
CPT0175060003	Tumor	0.3
CPT0168080003	Tumor	0.3
CPT0189460003	Tumor	0.3
CPT0127420003	Tumor	0.2
CPT0207090003	Tumor	0.2
CPT0087570003	Tumor	0.2
CPT0087950003	Tumor	0.2
CPT0205570003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0093590003	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0216920008	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0168830003	Tumor	0.2
CPT0218690004	Tumor	0.1
CPT0206670004	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0167970003	Tumor	0.0
CPT0224330003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0162020003	Tumor	0.0
CPT0167640003	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0167530003	Tumor	0.0
CPT0092440003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0206110003	Tumor	0.0
CPT0078580003	Tumor	-0.1
CPT0224390004	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0219080004	Tumor	-0.1
CPT0218830004	Tumor	-0.1
CPT0071100003	Tumor	-0.1
CPT0205450004	Tumor	-0.1
CPT0218960004	Tumor	-0.1
CPT0171580008	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0168380003	Tumor	-0.2
CPT0206450003	Tumor	-0.2
CPT0206880003	Tumor	-0.2
CPT0206780003	Tumor	-0.2
CPT0087680003	Tumor	-0.3
CPT0104220003	Tumor	-0.3
CPT0224600003	Tumor	-0.3
CPT0189850004	Tumor	-0.3
CPT0161730003	Tumor	-0.3
CPT0228220003	Tumor	-0.3
CPT0196850003	Tumor	-0.3
CPT0217000004	Tumor	-0.4
CPT0217710008	Tumor	-0.4
CPT0218890004	Tumor	-0.4
CPT0206560003	Tumor	-0.4
CPT0167750004	Tumor	-0.4
CPT0168270003	Tumor	-0.5
CPT0162100003	Tumor	-0.5
CPT0182550003	Tumor	-0.5
CPT0168720003	Tumor	-0.5
CPT0189250003	Tumor	-0.6
CPT0168590003	Tumor	-0.6
CPT0167860004	Tumor	-0.6
CPT0201710003	Tumor	-0.6
CPT0208980003	Tumor	-0.7
CPT0182580003	Tumor	-0.7
CPT0217880003	Tumor	-0.8
CPT0206330003	Tumor	-0.8
CPT0162140003	Tumor	-0.9
CPT0190240004	Tumor	-1.1
CPT0104330003	Tumor	-1.1
CPT0218770003	Tumor	-1.2
CPT0204340003	Normal	-1.2
CPT0204370003	Normal	-1.3
CPT0204420003	Normal	-1.3
CPT0204380003	Normal	-1.4
CPT0204330003	Normal	-1.4
CPT0204350003	Normal	-1.4
CPT0204410003	Normal	-1.5
CPT0204400003	Normal	-1.6
CPT0204360003	Normal	-1.6
CPT0204390003	Normal	-1.6
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA001762	Antibody CAB000080	Antibody CAB058687
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, NOS
Glioma, malignant, Low grade